When introduced with a new immunosuppressant treatment, people with systemic lupus erythematosus (SLE) typically see clinical improvement of extrarenal flares within 6 months. A new study published in Lupus Science & Medicine found extrarenal flare activity responds well to a rapid response to established therapy, and clinically significant improvements can be achieved within 3 months of starting a new treatment.
Researchers observed a group of 81 people with lupus over a 12-month period who were experiencing extrarenal flares and had a treatment change (both conventional and biologic drugs). They found that 3 months after starting a new immunosuppressant therapy, one-third of their flares were in remission, and 40% achieved low disease activity, regardless of whether a conventional or biological immunosuppressant therapy was administered. Over time, 64% of the participants achieved low disease activity and 42% reached remission by 6 months. By 12 months, 60% of the participants achieved low disease activity and 48% achieved remission.
This study suggests that a 6-month period from the start of a new therapy could be the time to evaluate a treat-to-target approach in lupus treatment. Consult your physician before making any changes to your treatment plan. Treating lupus is a team effort where people with the disease work with their doctors to find the best treatment plan for them. Learn more about treating lupus.
This post was originally published on this site